衰弱与2型糖尿病患者骨折风险
本研究基于前瞻性队列数据,探讨衰弱是否与骨折风险相关,以及衰弱是否可改变2型糖尿病对骨折风险的增加倾向。主要结局为首次临床脆性骨折时间,次要结局包括髋部骨折和临床脊柱骨折时间;衰弱状态用缺陷累积的衰弱指数(FI)衡量,采用含交互项(衰弱×糖尿病)的Cox模型分析。结果显示,2型糖尿病患者比无糖尿病者更衰弱,衰弱增加脆性骨折风险并增强糖尿病对脆性骨折的影响,但对髋部骨折和临床脊柱骨折未发现衰弱与糖尿病的交互作用。
要点
- 2型糖尿病患者比无糖尿病者更衰弱,且骨密度更高。
- 衰弱指数每增加0.01和0.10,脆性骨折风险分别增加2%和19%。
- 衰弱与糖尿病对脆性骨折风险存在显著交互作用(P=0.018)。
核心结论
- 2型糖尿病患者显著比无糖尿病者更衰弱。
- 衰弱增加脆性骨折风险并增强糖尿病对脆性骨折的影响。
- 对衰弱者应特别关注糖尿病作为脆性骨折的危险因素。
研究设计与样本
- 前瞻性队列研究,纳入3149名参与者(70%为女性),其中138名(60%为女性)患有糖尿病。
- 主要结局为首次临床脆性骨折时间,次要结局为髋部骨折和临床脊柱骨折时间。
- 衰弱状态用缺陷累积的衰弱指数(FI)衡量,采用含交互项(衰弱×糖尿病)的Cox模型分析。
主要发现
- 糖尿病患者比无糖尿病者骨密度更高且FI更高。
- FI与脆性骨折风险显著相关,每增加0.01和0.10的HR分别为1.02(95%CI 1.01-1.03)和1.19(95%CI 1.10-1.33)。
- 衰弱与糖尿病的交互作用显著(P=0.018);结合FI本身和交互项估计,FI每增加0.1,糖尿病患者HR为1.33,无糖尿病者为1.19。
- 对髋部骨折和临床脊柱骨折风险,未发现衰弱与糖尿病的交互作用证据。
临床怎么用
- 对2型糖尿病患者应评估衰弱状态,尤其关注衰弱者的脆性骨折风险。
- 衰弱指数可辅助识别脆性骨折高危的糖尿病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to explore whether frailty was associated with fracture risk and whether frailty could modify the propensity of type 2 diabetes toward increased risk of fractures. RESEARCH DESIGN AND METHODS: Data were from a prospective cohort study. Our primary outcome was time to the first incident clinical fragility fracture; secondary outcomes included time to hip fracture and to clinical spine fracture. Frailty status was measured by a Frailty Index (FI) of deficit accumulation. The Cox model incorporating an interaction term (frailty × diabetes) was used for analyses. RESULTS: The analysis included 3,149 (70% women) participants; 138 (60% women) had diabetes. Higher bone mineral density and FI were observed in participants with diabetes compared with control subjects. A significant relationship between the FI and the risk of incident fragility fractures was found, with a hazard ratio (HR) of 1.02 (95% CI 1.01-1.03) and 1.19 (95% CI 1.10-1.33) for per-0.01 and per-0.10 FI increase, respectively. The interaction was also statistically significant (P = 0.018). The HR for per-0.1 increase in the FI was 1.33 for participants with diabetes and 1.19 for those without diabetes if combining the estimate for the FI itself with the estimate from the interaction term. No evidence of interaction between frailty and diabetes was found for risk of hip and clinical spine fractures. CONCLUSIONS: Participants with type 2 diabetes were significantly frailer than individuals without diabetes. Frailty increases the risk of fragility fracture and enhances the effect of diabetes on fragility fractures. Particular attention should be paid to diabetes as a risk factor for fragility fractures in those who are frail.
引用
- Li G, Prior JC, Leslie WD, et al. Frailty and Risk of Fractures in Patients With Type 2 Diabetes. Diabetes Care. 2019. PMID: 30692240. doi:10.2337/dc18-1965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。